Furthermore, these results are consistent with our observation that NR4A1 does not induce myeloid differentiation gene programs and, therefore, does not likely play an opposing role to the anti-differentiation transcriptional profile observed for AML-ETO [68–70]. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.